Drug Shortage Report for GLN-ATOVAQUONE
Report ID | 236216 |
Drug Identification Number | 02528495 |
Brand name | GLN-ATOVAQUONE |
Common or Proper name | Mepron |
Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ATOVAQUONE |
Strength(s) | 750MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 210 ml Bottle |
ATC code | P01AX |
ATC description | AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS. |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2024-08-29 |
Actual start date | 2024-08-29 |
Estimated end date | 2024-10-09 |
Actual end date | 2024-10-16 |
Shortage status | Resolved |
Updated date | 2024-10-17 |
Company comments | RESOLVED |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2024-10-17 | English | Compare |
v11 | 2024-10-16 | French | Compare |
v10 | 2024-10-16 | English | Compare |
v9 | 2024-09-27 | French | Compare |
v8 | 2024-09-27 | English | Compare |
v7 | 2024-09-27 | French | Compare |
v6 | 2024-09-27 | English | Compare |
v5 | 2024-09-26 | French | Compare |
v4 | 2024-09-26 | English | Compare |
v3 | 2024-08-30 | English | Compare |
v2 | 2024-08-29 | French | Compare |
v1 | 2024-08-29 | English | Compare |
Showing 1 to 12 of 12